TP53 and hepatocellular carcinoma: A recent study reports that p53 haploinsufficiency and increased mTOR signaling, which are frequently observed in HCC, play an important role in a subset of aggressive HCC and indicate that the inhibition of mTOR may diminish tumor-promoting activity associated with p53 haploinsufficiency and provide a potential therapeutic strategy for the treatment of aggressive HCC [33].